Lipid Metabolism as a Source of Druggable Targets for Antiviral Discovery against Zika and Other Flaviviruses
The Zika virus (ZIKV) is a mosquito-borne flavivirus that can lead to birth defects (microcephaly), ocular lesions and neurological disorders (Guillain-Barré syndrome). There is no licensed vaccine or antiviral treatment against ZIKV infection. The effort to understand the complex interacti...
Main Authors: | Miguel A. Martín-Acebes, Nereida Jiménez de Oya, Juan-Carlos Saiz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/12/2/97 |
Similar Items
-
Insights into Structures and Dynamics of Flavivirus Proteases from NMR Studies
by: Qingxin Li, et al.
Published: (2020-04-01) -
The Dual Regulation of Apoptosis by Flavivirus
by: Yuhong Pan, et al.
Published: (2021-03-01) -
Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
by: Miguel A. Martín-Acebes, et al.
Published: (2018-02-01) -
The Multiples Fates of the Flavivirus RNA Genome During Pathogenesis
by: Clément Mazeaud, et al.
Published: (2018-12-01) -
Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus
by: Juan-Carlos Saiz, et al.
Published: (2018-08-01)